Para depositar en Docta Complutense, identifícate con tu correo @ucm.es en el SSO institucional. Haz clic en el desplegable de INICIO DE SESIÓN situado en la parte superior derecha de la pantalla. Introduce tu correo electrónico y tu contraseña de la UCM y haz clic en el botón MI CUENTA UCM, no autenticación con contraseña.

The impact of COVID-19 on DTP3 vaccination coverage in Europe (2012–2023)

dc.contributor.authorAguinaga Ontoso, Inés
dc.contributor.authorGuillen Aguinaga, Sara
dc.contributor.authorGuillen Aguinaga, Laura
dc.contributor.authorAlas Brun, Rosa
dc.contributor.authorGuillen Aguinaga, Miriam
dc.contributor.authorOnambele, Luc
dc.contributor.authorAguinaga Ontoso, Enrique
dc.contributor.authorRayón Valpuesta, Esperanza
dc.contributor.authorGuillen Grima, Francisco
dc.date.accessioned2026-01-21T18:06:20Z
dc.date.available2026-01-21T18:06:20Z
dc.date.issued2024-12-24
dc.description.abstractBackground: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.
dc.description.departmentDepto. de Enfermería
dc.description.facultyFac. de Enfermería, Fisioterapia y Podología
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.citationAguinaga-Ontoso, I.; Guillen-Aguinaga, S.; Guillen-Aguinaga, L.; Alas-Brun, R.; Guillen-Aguinaga, M.; Onambele, L.; Aguinaga-Ontoso, E.; Rayón-Valpuesta, E.; Guillen-Grima, F. The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023). Vaccines 2025, 13, 6. https://doi.org/10.3390/vaccines13010006
dc.identifier.doihttps://doi.org/10.3390/vaccines13010006
dc.identifier.essn2076-393X
dc.identifier.officialurlhttps://doi.org/10.3390/vaccines13010006
dc.identifier.relatedurlhttps://www.mdpi.com/2076-393X/13/1/6
dc.identifier.urihttps://hdl.handle.net/20.500.14352/130760
dc.issue.number1, 6
dc.journal.titleVaccines (Basel)
dc.language.isoeng
dc.page.final43
dc.page.initial1
dc.publisherMDPI
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu61
dc.subject.keywordDTP3 vaccination
dc.subject.keywordCOVID-19 pandemic impact
dc.subject.keywordvaccination trends
dc.subject.keywordEurope
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.titleThe impact of COVID-19 on DTP3 vaccination coverage in Europe (2012–2023)
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number13
dspace.entity.typePublication
relation.isAuthorOfPublication14c3dda5-34f1-4b02-8637-994958ec8a27
relation.isAuthorOfPublication.latestForDiscovery14c3dda5-34f1-4b02-8637-994958ec8a27

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Impact_COVID-19_DTP3_Vaccination.pdf
Size:
8.09 MB
Format:
Adobe Portable Document Format

Collections